Imajte na umu da ako ste mlađi od 18 godina, nećete moći pristupiti ovoj stranici.
Imate li 18 ili više godina?
Učitaj
Uvoz
Moj račun
Način rada
Prijaviti se
Registar
VJHemOnc Podcast
|
Pretplatnici
Pretplatite se
0
Video zapisi
Popisi za reprodukciju
Sviđa mi se videozapisi
Oko
Najnoviji video zapisi
28:07
iwAL 2023 Session II: Novel treatments in AML: FLT3 inhibitors, combinations, and more
VJHemOnc Podcast
1 Pogledi
·
2 godine prije
18:05
iwAL 2023 Session I: Clonal hematopoiesis in AML, early detection and potential therapeutics
VJHemOnc Podcast
0 Pogledi
·
2 godine prije
10:51
Applications of MRD in multiple myeloma: using MRD to guide treatment decisions
VJHemOnc Podcast
0 Pogledi
·
2 godine prije
16:52
The importance of addressing racial disparities & differences in survival in patients with acute leukemias
VJHemOnc Podcast
0 Pogledi
·
2 godine prije
10:05
Pre-MDS states: improving prognosis, novel therapeutic approaches, and challenges with distinguishing these conditions
VJHemOnc Podcast
0 Pogledi
·
2 godine prije
08:17
Accelerated-phase MPNs: mutational landscape, challenges, and novel treatment strategies being explored
VJHemOnc Podcast
0 Pogledi
·
2 godine prije
07:07
Determining the optimal sequencing of bispecifics and CAR-T cells in multiple myeloma
VJHemOnc Podcast
0 Pogledi
·
2 godine prije
11:27
Overcoming barriers to CAR-T therapy: improving access and cost
VJHemOnc Podcast
0 Pogledi
·
2 godine prije
06:14
The importance of addressing quality of life and improving symptom management in MPNs
VJHemOnc Podcast
0 Pogledi
·
2 godine prije
06:47
Hemophilia: the current standard of care and the value of novel gene therapies
VJHemOnc Podcast
0 Pogledi
·
2 godine prije
14:14
CLL highlights at EHA 2023: latest advances with the use of BTK inhibitors
VJHemOnc Podcast
0 Pogledi
·
2 godine prije
08:24
Myeloma highlights at EHA 2023: CARTITUDE-4 & CARTITUDE-1 updates & the use of MRD in clinical practice
VJHemOnc Podcast
0 Pogledi
·
2 godine prije
16:48
Lymphoma highlights at EHA 2023: sequencing bispecifics & CAR-T cells, bridging therapy & toxicity management
VJHemOnc Podcast
0 Pogledi
·
2 godine prije
10:14
The importance of genomic testing in CLL and its role in clinical decision-making
VJHemOnc Podcast
0 Pogledi
·
3 godine prije
17:59
iwNHL Session IV: T-cell therapies for NHL: CAR-T therapies & third-party EBV T-cells
VJHemOnc Podcast
0 Pogledi
·
3 godine prije
11:35
Key updates in CLL: novel treatment strategies, the changing role of chemotherapy, and more
VJHemOnc Podcast
0 Pogledi
·
3 godine prije
16:02
iwAL 2022 Session IV: The evolving treatment landscape in ALL and the growing role of immunotherapies
VJHemOnc Podcast
0 Pogledi
·
3 godine prije
11:22
iwNHL Session III: Exploring the optimal management of R/R follicular lymphoma in an expanding treatment landscape
VJHemOnc Podcast
0 Pogledi
·
3 godine prije
15:43
Recent updates in CML: treatment strategies, clinical trials, and novel agents
VJHemOnc Podcast
0 Pogledi
·
3 godine prije
13:38
iwNHL Session II: Understanding and harnessing the immune microenvironment against lymphoma
VJHemOnc Podcast
0 Pogledi
·
3 godine prije
Prikaži više
Dom
Najnoviji video zapisi
U trendu
Najbolji videi
Popularni kanali
Istražite više
Pomozite
Odaberite način plaćanja
Jezik
English
Arabic
Dutch
French
German
Russian
Spanish
Turkish
Hindi
Chinese
Urdu
Indonesian
Croatian
Hebrew
Bengali
Japanese
Portuguese
Italian
Persian
Swedish
Vietnamese
Danish
Filipino
Plaćanje novčanikom
Prijaviti se
Korisničko ime
Zaporka
Zaboravili ste zaporku?
Zapamtite ovaj uređaj
Prijavite se sa
Novi ovdje?
Registar
Prijavite se!
Korisničko ime
Email adresa
Zaporka
Mora imati najmanje 6 znakova.
Mora sadržavati malo slovo.
Mora sadržavati veliko slovo.
Mora sadržavati broj ili poseban znak.
Potvrdi lozinku
Muški
Žena
Stvaranjem svog računa pristajete na naše
Uvjeti korištenja
&
Politika privatnosti
Već imate račun?
Prijaviti se